We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Maternal Multiomic Changes Could Predict Onset of Labor

By LabMedica International staff writers
Posted on 18 May 2021
Currently, predictions of when labor will start are imprecise and based on gestational age and an average pregnancy length of 40 weeks, even though the onset of labor between week 37 and 42 of pregnancy is considered normal. More...
Having a better idea of when labor may arrive could help with planning and managing medical concerns like fetal lung maturation.

As pregnancy progresses toward labor, major transitions occur in fetomaternal immune, metabolic, and endocrine systems that culminate in birth. The comprehensive characterization of maternal biology that precedes labor is crucial to understanding these physiological transitions and identifying predictive biomarkers of delivery.

A large team of multidisciplinary scientists led by Stanford University School of Medicine (Palo Alto, CA, USA) followed more than 60 women toward the end of their pregnancies, collecting blood samples for metabolic, protein, and immune analysis. They collected a median of three blood samples from each participant within the 100 days preceding labor. Using untargeted mass spectrometry and an aptamer-based proteomic platform, the team tallied the levels of 3,529 metabolites and 1,317 proteins, while using a mass cytometry assay to gauge nearly 2,300 immune features over time.

The investigators pieces together a picture of the changes that occur in the two to four weeks prior to delivery. For instance, the levels of steroid hormones like progesterone and cortisol rose dramatically. At the same time, levels of factors involved in angiogenesis fell; a change they said could help weaken the connection between the uterus and the placenta, priming them for delivery.

Additional shifts affected the immune system. There was a rise in interleukin-1 receptor type 4 (IL-1R4) levels, which inhibits the inflammatory factor IL-33, suggesting that this change may tamp down inflammatory responses that might otherwise be triggered during labor. In addition, the increase in IL-1R4 levels could serve a labor-initiation signal. By feeding these changes into a model, the scientists developed a tool to predict when someone is about to go into labor. After training on their 53 cohort members, they tested their predictor on data from a further 10 women to find that it had high accuracy in predicting the time to labor. They further noted that the model could predict both preterm and term labor.

Virginia Winn, MD, an associate professor of obstetrics and gynecology and co-author of the study, said, “If we understand what's regulating labor, we might be able to do a better job of inducing labor.” The study was published on May 5, 2021 in the journal Science Translational Medicine.


Related Links:
Stanford University School of Medicine


Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
Rapid Sepsis Test
SeptiCyte RAPID
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image Credit: Shutterstock

New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia with limited treatment options and a poor prognosis. Although tagraxofusp is the first approved targeted therapy for... Read more

Immunology

view channel
Image:Proteomic tear-fluid analysis revealed abnormal patterns in proteins that regulate nerves and T cells in individuals with eye problems (Image Credit: Adobe Stock)

Diagnostic Models Detect Hidden Eye Abnormalities After Mild COVID-19

Persistent ocular symptoms after COVID-19 can severely affect reading, work, and daily tasks, yet standard eye exams often reveal no clear abnormalities. Patients experiencing photophobia, eye pain, and... Read more

Industry

view channel
Photo courtesy of Natera

Natera’s Signatera Earns IVDR Certification for Solid Tumor MRD Testing

Natera’s Signatera has received certification as a Class C device under the European Union’s In Vitro Diagnostic Regulation (IVDR), becoming the first personalized MRD test for solid tumors to achieve... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.